Sunghee Cho

Sunghee Cho is a notable inventor based in Scarsdale, NY (US). He has made significant contributions to the field of biomedical research, particularly in the treatment of diabetes. With a total of 6 patents to his name, his work focuses on innovative methods that address critical health issues.

Latest Patents

One of his latest patents involves methods for reducing CD36 expression. This invention provides a method for treating one or more complications of diabetes in a mammal. The method comprises administering to a mammal in need thereof an effective amount of an aromatic-cationic peptide having at least one net positive charge. The peptide must have a minimum of four amino acids and a maximum of about twenty amino acids. Additionally, there is a specific relationship between the minimum number of net positive charges (p) and the total number of amino acid residues (r), wherein 3p is the largest number that is less than or equal to r+1. Furthermore, there is a relationship between the minimum number of aromatic groups (a) and the total number of net positive charges (p), wherein 2a is the largest number that is less than or equal to p+1, except that when a is 1, p may also be 1.

Career Highlights

Sunghee Cho is associated with the Cornell Research Foundation Inc., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on diabetes treatment and management.

Collaborations

He collaborates with esteemed colleagues such as Hazel Szeto and Shaoyi Liu, contributing to a dynamic research environment that fosters innovation.

Conclusion

Sunghee Cho's contributions to the field of diabetes research through his innovative patents highlight his role as a significant inventor. His work not only showcases his expertise but also holds promise for improving health outcomes for many individuals.

This text is generated by artificial intelligence and may not be accurate.